Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Patent reform and lower drug prices should be bipartisan priorities
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
Dec 2022: Year in Review – Historic Progress on Patent Reform
How AbbVie denied Americans access to fair competition for Humira
Nov 2022: MacArthur, Growing Momentum, and Much More
Life-Changing Drug Costs Over $3,000 in US, $0 to $225 in Europe
Oct 2022: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices.
Report pulls no punches in critique of drug patent abuse
Consumer group says drugmakers abuse U.S. patent system to keep prices high
Gaming of U.S. Patent System Is Keeping Drug Prices Sky High